Carotid angioplasty, officially known as percutaneous transluminal carotid angioplasty and stenting (CAS), is an endovascular intervention performed within vascular surgery, interventional cardiology, neurology, and interventional radiology. The primary goal of the procedure is stroke prevention. It addresses carotid artery stenosis, a condition characterized by the accumulation of atherosclerotic plaque (fatty deposits and calcified debris) in the main arteries of the neck that supply blood to the brain. By expanding the narrowed vessel lumen and stabilizing unstable plaque under embolic protection, carotid angioplasty reduces the risk of clot formation and distal embolization (plaque fragments traveling to cerebral arteries).

Carotid angioplasty and stenting is performed in a specialized catheterization laboratory equipped with high-resolution digital subtraction angiography (DSA). The patient is positioned supine, and continuous monitoring of arterial blood pressure, continuous electrocardiogram (ECG), and oxygen saturation is established. Local anesthetic is infiltrated over the puncture site—most commonly the right common femoral artery or right radial artery. Under fluoroscopic guidance, a vascular sheath is inserted into the artery using the Seldinger technique. A guide catheter or long shaped sheath is advanced over a guidewire into the common carotid artery proximal to the target stenosis. Heparin is administered intravenously to achieve an activated clotting time (ACT) of 250 to 300 seconds, minimizing intra-procedural thrombus formation.

Next, a specialized embolic protection device (EPD)—typically a porous metallic umbrella-like filter mounted on a micro-guidewire—is carefully navigated across the stenosis and deployed in the distal internal carotid artery. This filter acts as a safety basket, capturing microscopic plaque fragments and blood clots dislodged during vessel manipulation while allowing continuous blood perfusion to the brain. Once the protection filter is verified in position, a small-diameter balloon catheter may be advanced over the wire to perform pre-dilation of dense or tight lesions. A self-expanding nitinol stent sized precisely to the patient's vessel anatomy is then deployed across the diseased arterial segment, spanning at least 5 to 10 millimeters beyond the proximal and distal edges of the plaque.

Following stent deployment, post-dilation balloon angioplasty is performed using a non-compliant or semi-compliant balloon to fully expand the stent struts against the vessel wall and maximize the internal luminal diameter. Prior to post-dilation, atropine may be administered intravenously to prevent or mitigate baroreceptor-mediated bradycardia and hypotension caused by balloon pressure on the carotid sinus. Contrast angiography is performed to verify stent expansion, vessel patency, and intact intracranial blood flow. The embolic protection filter is then collapsed, recaptured into a retrieval catheter, and removed from the body. Finally, the main sheath is removed, and the arterial access site is sealed using a vascular closure device or manual compression.

Carotid angioplasty offers several established clinical advantages for appropriate candidates. As a minimally invasive endovascular approach, it avoids a direct neck incision, thereby preserving surrounding anatomical structures and eliminating the risk of cranial nerve injuries (such as damage to the hypoglossal, facial, or vagus nerves), which can occur in 2% to 7% of open surgical cases (CREST Trial, Brott et al., NEJM 2010). The procedure is performed under local anesthesia and light sedation, eliminating the risks associated with general anesthesia in patients with severe cardiopulmonary disease.

Additionally, carotid angioplasty significantly reduces hospital recovery time compared to open surgery, with most patients achieving full physical mobilization within 12 to 24 hours and returning to routine daily activities within several days. Large-scale randomized trials, such as the Second Asymptomatic Carotid Surgery Trial (ACST-2, Halliday et al., Lancet 2021), have demonstrated that modern carotid stenting achieves long-term stroke prevention outcomes comparable to open endarterectomy when performed by experienced operators using embolic protection devices.

Short-term recovery focuses on access-site healing and hemodynamic stabilization. In the first 24 hours post-procedure, strict bed rest is maintained for 2 to 6 hours depending on whether a vascular closure device or manual compression was used at the arterial access site. Neurological status, puncture site integrity, and vital signs—particularly blood pressure—are evaluated frequently. Transient hypotension (low blood pressure) and bradycardia (slow heart rate) may occur due to mechanical stretching of the carotid sinus baroreceptors during balloon expansion, occasionally requiring intravenous fluids or temporary vasoactive medications.

Long-term recovery involves lifestyle modification, blood pressure control, and compliance with antiplatelet therapy. Patients typically resume non-strenuous light activities within 48 to 72 hours and may return to driving after 1 to 2 weeks, pending clinical clearance. Dual antiplatelet therapy (aspirin combined with clopidogrel) is mandated for a minimum of 30 days to 3 months to prevent acute and subacute stent thrombosis, followed by lifelong single antiplatelet therapy. A surveillance baseline carotid duplex ultrasound is obtained at 1 month, followed by imaging at 6 and 12 months, and annually thereafter to assess stent patency and evaluate for in-stent restenosis (re-narrowing within the stent).

Carotid angioplasty is indicated for the treatment of significant carotid artery stenosis (narrowing of the neck arteries due to atherosclerosis). Specifically, it treats symptomatic carotid stenosis (defined as a prior stroke, transient ischemic attack [TIA], or amaurosis fugax within the preceding six months attributable to an ipsilateral blockage of 50% to 99%) and severe asymptomatic carotid stenosis (typically 70% to 99% narrowing without recent symptoms). It is frequently selected for individuals categorized as high surgical risk for open carotid endarterectomy due to anatomical factors, prior neck irradiation, recurrent stenosis (restenosis), or severe cardiac and pulmonary comorbidities.

Patient preparation for carotid angioplasty involves a comprehensive clinical and diagnostic evaluation to ensure procedural safety and efficacy. Diagnostic workup begins with anatomical imaging, including high-resolution carotid duplex ultrasonography to quantify flow velocities, supplemented by computed tomography angiography (CTA) or magnetic resonance angiography (MRA) of the head and neck. These cross-sectional imaging modalities evaluate plaque burden, degree of calcification, aortic arch morphology, vessel tortuosity, and intracranial collateral circulation. Baseline laboratory testing includes complete blood count, renal function panels (serum creatinine and estimated glomerular filtration rate) to assess contrast clearance, coagulation profiles, and baseline cardiac biomarkers.

Medical preparation focuses heavily on antiplatelet regimen optimization. Per clinical guidelines (AHA/ASA 2021), patients must receive dual antiplatelet therapy (DAPT) consisting of aspirin (75-325 mg daily) and clopidogrel (75 mg daily) for at least 3 to 5 days prior to the procedure. If urgent intervention is required, a loading dose of clopidogrel (300-600 mg) is administered. Patients taking oral anticoagulants (such as warfarin or direct oral anticoagulants) require a structured bridge protocol guided by a vascular specialist. On the day before the procedure, patients are instructed to fast for at least 6 to 8 hours prior to intervention, while continuing prescribed cardiac and antiplatelet medications with small sips of water. Adequate oral or intravenous hydration is maintained to reduce the risk of contrast-induced acute kidney injury.

Carotid angioplasty carries specific procedural and post-procedural risks that vary based on patient age, baseline anatomical characteristics, and clinical presentation (symptomatic versus asymptomatic status). The primary procedural risk is peri-procedural ischemic stroke or transient ischemic attack (TIA), occurring in approximately 2% to 6% of cases. Stroke can result from micro-embolization of plaque fragments during catheter manipulation, filter deployment, or stent expansion, as well as acute stent thrombosis.

Access site complications occur in 1% to 4% of patients and include groin or wrist hematoma, pseudoaneurysm formation, retroperitoneal hemorrhage, and arteriovenous fistula. Hemodynamic instability is common; balloon expansion across the carotid bifurcation stretches baroreceptors, triggering a vagal response that leads to transient hypotension and bradycardia in up to 30% to 40% of cases, though persistent hemodynamic depression requiring prolonged vasopressor support occurs in less than 5% to 10%. A rare but serious complication is cerebral hyperperfusion syndrome (CHS), occurring in 0.5% to 3% of patients following successful revascularization of severe chronic stenosis; rapid restoration of normal arterial pressure to a chronically ischemic brain with impaired autoregulation can cause severe headache, seizures, focal neurological deficits, and intracerebral hemorrhage. Long-term risks include in-stent restenosis due to neointimal hyperplasia, occurring in approximately 3% to 8% of patients within 2 years.

The clinical care pathway for carotid angioplasty begins with an extensive diagnostic evaluation, including carotid duplex ultrasound, computed tomography angiography (CTA), or magnetic resonance angiography (MRA) to map arterial anatomy and plaque morphology. Before the procedure, patients undergo pre-procedure medical optimization, which includes pre-loading with dual antiplatelet therapy (DAPT) such as aspirin and clopidogrel. On the day of intervention, the procedure is performed in a specialized catheterization laboratory under local anesthesia with conscious sedation. Access is gained through the femoral or radial artery, a flexible catheter is navigated to the carotid artery, an embolic protection filter is deployed, and balloon dilation with stent placement is completed in 60 to 90 minutes. Following the procedure, patients are monitored overnight in a high-dependency or intermediate care unit for precise blood pressure control and neurological assessments. Most patients are discharged on post-procedure day one with a structured follow-up plan involving periodic vascular ultrasounds and long-term antiplatelet management.